The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial

被引:0
作者
Tao Bai
Haoyu Zeng
Yanqin Long
Xiaoqing Li
Xiaohong Sun
Yu Lan
Lingling Gao
Lu Zhang
Zenghui Feng
Xiaohua Hou
机构
[1] Huazhong University of Science and Technology,Division of Gastroenterology, Union Hospital, Tongji Medical College
[2] Zhejiang University School of Medicine,Division of Gastroenterology, Sir Run Run Shaw Hospital
[3] Peking Union Medical College Hospital,Division of Gastroenterology
[4] Beijing Jishuitan Hospital,Division of Gastroenterology
[5] Peking University Clinical Research Institute,undefined
[6] Hangzhou Grand Biologic Pharmaceutical. INC,undefined
来源
Trials | / 21卷
关键词
Irritable bowel syndrome; Diarrhea predominant IBS; Randomized controlled trial; Efficacy; Probiotics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 110 条
[1]  
Longstreth GF(2006)Functional bowel disorder Gastroenterology 130 1480-1491
[2]  
Thompson WG(2016)The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review Gut 66 1075-1082
[3]  
Chey WD(2017)Comparison of the Rome IV and Rome III criteria for IBS diagnosis: a cross-sectional survey J Gastroenterol Hepatol 32 1018-1025
[4]  
Sperber AD(2012)Diagnosis and management of IBS in adults Am Fam Physician 86 419-426
[5]  
Dumitrascu D(2016)Update on the management of diarrhea-predominant irritable bowel syndrome: focus on rifaximin and eluxadoline Pharmacotherapy 36 300-316
[6]  
Fukudo S(2014)A role for the gut microbiota in IBS Nat Rev Gastroenterol Hepatol 11 497-505
[7]  
Gerson C(2017)Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol 312 G52-G62
[8]  
Ghoshal UC(2014)Manipulation of the microbiota for treatment of IBS and IBD—challenges and controversies Gastroenterology 146 1554-1563
[9]  
Gwee KA(2017)Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome Postgrad Med 129 872-888
[10]  
Whitehead W(2017)Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis J Gastroenterol Hepatol 32 28-38